What Happens When Cancer Spreads to the Spine?

When cancer spreads to the spine, tumor cells settle into the vertebral bone and begin to disrupt its structure, causing pain, weakening the bone enough to fracture, and sometimes compressing the spinal cord or nerves. The spine is one of the most common sites for cancer metastasis, with lung, prostate, and breast cancers accounting for the majority of cases. What follows is rarely a single event but rather an evolving condition that requires a combination of treatments to manage pain, preserve mobility, and protect the spinal cord from irreversible damage.

Which Cancers Are Most Likely to Spread to the Spine

Not all cancers target the spine equally. A large study examining metastatic patterns found that lung cancer was the most common source of spinal metastases, responsible for about 21% of cases, followed by prostate cancer at 19% and breast cancer at 12%.¹ Kidney cancer, thyroid cancer, and colorectal cancer also spread to the spine with meaningful frequency. The vertebral column’s rich blood supply partly explains why it catches so many circulating tumor cells. A network of veins running along the spine, sometimes called Batson’s plexus, connects to veins draining the pelvis, chest, and abdomen, giving cancer cells from multiple organ sites a direct route into vertebral bone.²

What Cancer Does to the Bone Once It Arrives

Once tumor cells lodge in the spine, they hijack the normal cycle of bone breakdown and rebuilding. Healthy bone is constantly being remodeled: one type of cell tears down old bone while another type builds new bone behind it. Cancer throws this balance off. Some tumors stimulate excessive bone destruction, leaving holes and weak spots (called osteolytic lesions). Others trigger chaotic new bone formation that is structurally abnormal (osteoblastic lesions). Most patients end up with some combination of both.³

The practical consequence is that the vertebra becomes weaker. Bone that once supported your body weight and absorbed the forces of everyday movement can no longer do so reliably. This weakness is what leads to the three hallmark problems of spinal metastases: pain, fracture, and spinal cord compression. A vertebra weakened by tumor may collapse partially or completely under normal loading, and if bone fragments or tumor tissue push into the spinal canal, the spinal cord itself can be squeezed. That compression is a medical emergency because nerve damage from a compressed spinal cord can become permanent if not treated quickly.

How Spinal Metastases Are Found

Pain is usually what brings people in. The classic presentation is back pain that worsens at night or doesn’t improve with rest, which distinguishes it from the ordinary muscle strain or disc problem. But confirming that cancer is behind the pain requires imaging, and the choice of imaging matters.

MRI is the gold standard. A meta-analysis comparing all the major imaging methods for detecting vertebral metastases found that MRI had the best overall diagnostic accuracy, outperforming CT scans, PET scans, and traditional bone scans.⁴ A head-to-head comparison found MRI detected about 98.5% of spinal lesions, while CT caught only about 66%.⁵ MRI is particularly good at spotting disease that is still confined to the bone marrow, before the outer bone shell has been damaged enough for other scans to notice. CT remains useful for assessing how much structural damage has already occurred and for surgical planning, but it misses early-stage disease more often.⁶

Deciding on Treatment

Spinal metastases rarely have one simple fix. Treatment planning typically weighs four factors: how much the spinal cord is being affected, how sensitive the particular tumor type is to radiation, how stable the spine still is mechanically, and how well the patient can tolerate treatment overall. This framework, developed at Memorial Sloan-Kettering Cancer Center and known by the acronym NOMS, helps teams decide which combination of radiation, surgery, and systemic therapy makes the most sense for a given patient.⁷

Assessing spinal stability is one of the trickier parts. Doctors use a scoring tool called the Spinal Instability Neoplastic Score, or SINS, which grades the vertebra’s location, pain characteristics, bone quality, degree of collapse, and alignment. The tool has shown strong agreement among different clinicians scoring the same patient, which makes it reliable for deciding who needs stabilization surgery and who can safely be managed without it.⁸

Radiation Therapy for Spinal Tumors

Radiation is the most commonly used treatment for spinal metastases. Conventional radiation, delivered over multiple sessions in relatively broad beams, has been the standard for decades. It controls pain and slows tumor growth, but its track record for keeping tumors from regrowing at the treated site is modest, with reported control rates hovering between roughly 60% and 86% at one year.

Stereotactic body radiotherapy, or SBRT, is a newer approach that delivers a high dose of radiation with pinpoint accuracy in just one to a few sessions. Local control with SBRT ranges from about 80% to 96% at one year, and it works even against tumor types traditionally considered resistant to radiation, such as melanoma and kidney cancer.⁹ In a randomized trial of 229 patients, SBRT produced a complete pain response in about 35% of patients at three months compared to 14% with conventional radiation, and the pain advantage held at six months. Longer-term follow-up also showed a lower risk of the tumor coming back and less need for re-treatment.¹⁰

SBRT is not suitable for everyone. It works best when the tumor is not directly pressing on the spinal cord and when the spine is stable enough that the patient does not also need surgery. For tumors already compressing the cord, surgery to create space may come first, with SBRT following to kill remaining cancer cells.

When Surgery Is Needed

Surgery for spinal metastases is not about curing the cancer. Its goals are to relieve pressure on the spinal cord, stabilize a spine that can no longer support itself, and reduce pain. These operations typically involve removing tumor tissue that is compressing the cord and then anchoring the spine with metal rods and screws.

The results can be dramatic for patients who are losing neurological function. In one study of patients with metastatic spinal cord compression, only about 23% could walk independently before surgery, but by six months after the operation, nearly 69% had recovered to that level. Pain scores dropped substantially as well, falling from an average of about 6 out of 10 before surgery to roughly 2 out of 10 at six months.¹¹

Where the tumor sits along the spine influences outcomes somewhat. Cervical spine metastases (in the neck) carry a higher risk of worsening motor function after surgery compared to tumors lower down. One study found that about 37% of patients with cervical metastases experienced some deterioration in motor function after surgery, compared to 18% with thoracic and 13% with lumbar disease. Despite this, survival after surgery was similar regardless of location, with median survival around 11 months across all three groups.¹²

Interestingly, for patients whose primary problem is instability and pain rather than cord compression, adding a decompression procedure (removing bone or tissue from around the nerves) on top of stabilization does not seem to improve function compared to stabilization alone. A multicenter prospective study found no significant difference in functional improvement between the two approaches at either one month or six months.¹³ This matters because less extensive surgery generally means fewer complications and faster recovery.

Cement Procedures for Collapsed Vertebrae

When a vertebra has collapsed from tumor damage but the spinal cord is not being compressed, a less invasive option is vertebral augmentation. These procedures involve injecting medical-grade bone cement into the damaged vertebra through a needle, essentially filling and reinforcing the weakened bone from the inside. The two main techniques are vertebroplasty, which injects cement directly, and kyphoplasty, which first inflates a small balloon to restore some of the lost height before filling the space with cement.

Pain relief is typically rapid. Studies consistently show significant drops in pain scores within 48 hours, along with reduced need for pain medications, particularly opioids.¹⁴ A study of 282 patients who underwent kyphoplasty for spinal metastases found that pain dropped significantly, analgesic use decreased, and the kyphotic angle (the hunching deformity from the collapsed vertebra) improved, with the correction lasting at least a year.¹⁵ Both vertebroplasty and kyphoplasty provide comparable pain relief, though kyphoplasty tends to have lower rates of cement leaking outside the vertebra.¹⁶

Bone-Targeted Drugs

Alongside local treatments like radiation and surgery, most patients with spinal metastases receive medications specifically aimed at slowing bone destruction. Two classes are widely used: bisphosphonates (such as zoledronic acid, given intravenously) and denosumab (a subcutaneous injection). Both work by dialing down the activity of cells that break down bone, reducing the risk of fractures, cord compression, and other skeletal complications.

Head-to-head comparisons in meta-analyses have found that denosumab has a modest edge. It delays the time to first skeletal complications and reduces the need for radiation to bone compared to bisphosphonates.¹⁷ When looking specifically at the likelihood of pathological fractures across all tumor types, denosumab was statistically superior.¹⁸

One particularly interesting finding is that denosumab may help avoid surgery for patients whose spinal stability is borderline. In patients with intermediate instability scores, those who received denosumab were about half as likely to eventually need surgery as those who did not. The drug also improved pain related to instability and promoted hardening of bone lesions that had previously been soft and weak.¹⁹ For patients hoping to avoid the operating room, this is a meaningful benefit.

Managing Pain Day to Day

Pain from spinal metastases is often the symptom that dominates daily life. It can be a constant dull ache from bone destruction, sharp and sudden if a vertebra fractures, or radiating down a leg or arm if a nerve root is being compressed. Pain management typically follows the World Health Organization’s analgesic ladder, starting with non-opioid medications and stepping up to stronger opioids as needed, alongside the tumor-directed treatments already discussed.²⁰ In practice, the best outcomes come from combining pain medication with radiation, surgery, or cement procedures when appropriate, rather than relying on drugs alone.

Why Walking Ability Matters So Much

Clinicians pay close attention to whether patients with spinal metastases can still walk, and not just for quality-of-life reasons. Research consistently shows a strong link between the ability to walk after treatment and how long patients survive. In one study, patients who regained the ability to walk by three months after surgery had a median survival of about 610 days, compared to 181 days for those who did not.²¹ Another study found that patients who recovered independent walking after surgery had a median survival of 16 months versus 5 months for those who did not.²²

This connection is probably not just about walking itself. Patients who regain mobility tend to be those whose overall cancer burden is more manageable and who tolerate treatment well. But mobility also protects against complications of immobility like blood clots, pneumonia, and muscle wasting, which can themselves shorten life. The practical takeaway is that preserving the ability to walk should be a high priority in treatment decisions, and delays in treating spinal cord compression can permanently close that window.

What predicts recovery? Speed matters. Patients whose neurological symptoms developed slowly, over more than a week before they lost the ability to walk, were far more likely to recover independent walking than those who declined rapidly.²³ Hip flexion strength before surgery is another useful predictor: patients who still had some strength in their hip flexors going into the operating room had significantly better odds of walking again afterward.²²

Rehabilitation and Protecting Your Spine

After treatment, physical and occupational therapy play a critical role, but rehabilitation for spinal metastases looks different from rehab after a typical back injury. The bone is compromised, and everyday activities create surprisingly large forces on the spine. A cadaver study found that vertebrae weakened by tumor had a mean failure load roughly 40% lower than healthy vertebrae.²⁴ That means activities you would not think twice about, like bending to tie your shoes or twisting to grab something from a back seat, can put dangerous stress on an affected vertebra.

Therapists working with these patients often use what is informally called the “No BLT” rule: minimize bending, lifting, and twisting. The goal is to keep the center of mass close to the spine and avoid the kinds of combined movements that amplify spinal loading. This does not mean becoming bedridden. In fact, staying as active as safely possible is the point. Therapists teach alternative ways to dress, bathe, get in and out of bed, and move through the day that reduce fracture risk while maintaining independence and engagement in daily life.²⁵

The Toll on Family Caregivers

Most of the medical literature on spinal metastases focuses on the patient, but the condition lands heavily on families as well. A systematic review of caregivers’ experiences found significant physical, emotional, and financial strain. Caregivers described the burden as coming from competing tasks, lack of knowledge about symptom management, and difficult experiences providing care at home.²⁶

Research from China found that roughly 85% of family caregivers of elderly patients with spinal tumors reported a moderate or heavy burden. The patient’s level of pain was directly correlated with how burdened the caregiver felt, as was the degree of paralysis. Patients who needed more supervision and hands-on personal care unsurprisingly created a heavier load. Lower household income compounded everything.²⁷ Effective pain control and preserving the patient’s mobility are not just quality-of-life measures for the patient; they directly ease the strain on the people providing daily care.

Liquid Biopsies and What Is Coming Next

One area of active research is whether blood tests could one day replace or supplement some of the imaging and biopsy procedures used to monitor spinal metastases. So-called liquid biopsies look for fragments of tumor DNA, circulating tumor cells, or other molecular markers in a simple blood draw. The concept is appealing because imaging can only show you what the tumor looks like right now, while molecular markers could reveal whether the tumor is responding to treatment, evolving resistance, or spreading further, all from a routine blood sample.²⁸ The technology is still in early stages for spinal tumors specifically, but it is already used in some other cancer settings and could eventually change how patients with spinal metastases are monitored over time.